市場調查報告書

再生醫療的全球市場:各治療方法 (細胞療法,遺傳基因療法)、產品 (自我細胞/同種異體細胞/無細胞)、用途、地區的預測

Regenerative Medicine Market - Forecast (2020 - 2025)

出版商 IndustryARC 商品編碼 422454
出版日期 內容資訊 英文 103 Pages
商品交期: 2-3個工作天內
價格
再生醫療的全球市場:各治療方法 (細胞療法,遺傳基因療法)、產品 (自我細胞/同種異體細胞/無細胞)、用途、地區的預測 Regenerative Medicine Market - Forecast (2020 - 2025)
出版日期: 2020年03月11日內容資訊: 英文 103 Pages
簡介

本報告提供全球再生醫療的相關市場相關分析,關於產品概要和整體市場結構,主要的推動及阻礙市場要素,各治療法、各產品、各用途、各地區的市場趨勢預測 (今後7年份),市場競爭概況,近來的資本交易、策略發展的動向,主要企業簡介等調查評估。

第1章 再生醫療:市場概況

第2章 摘要整理

第3章 市場環境

  • 市場佔有率分析
  • 比較分析
  • 產品的互相比較
  • 終端用戶簡介
  • 前五名公司的財務分析

第4章 再生醫療市場影響要素

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 課題
  • 波特的五力分析

第5章 再生醫療市場:策略分析

  • 價值鏈分析
  • 價格趨勢分析
  • 市場機會分析
  • 產品/市場生命週期分析
  • 供應商、經銷商

第6章 再生醫療市場:各治療法

  • 細胞療法
  • 遺傳基因療法
  • 組織工程
  • 免疫療法

第7章 再生醫療市場:各產品

  • 自我細胞產品
  • 同種異體細胞產品
  • 無細胞產品

第8章 再生醫療市場:各用途

  • 整形外科、肌肉骨骼系統脊椎
  • 皮膚
  • 心血管
  • 中樞神經系統 (CNS)
  • 腫瘤
  • 糖尿病
  • 其他

第9章 再生醫療市場:各地區

  • 歐洲 (德國、法國、義大利、西班牙、俄羅斯、英國等)
  • 亞太地區 (中國、日本、印度、韓國等)
  • 北美 (美國、加拿大、墨西哥)
  • 其他的國家 (RoW) (巴西等)

第10章 再生醫療市場:市場變化的方向性

  • 產業擴張
  • 技術進步
  • 企業合併、收購 (M&A),合資企業
  • 供給契約

第11章 企業簡介

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HCR 0366

As per the Organ Procurement and Transplantation Network, 36,527 organ transplants were accomplished in the United States in 2018[1]. Regenerative medicines plays a vital role in transplants as it refers to an interdisciplinary field and is a branch of translational research that applies engineering and life science principles to promote regeneration, and can potentially restore diseased and injured tissues as well as whole organs. Apart from organ regeneration, regenerative medicines are effective in cell therapy, gene therapy, and tissue engineering, and are applicable in cardiology, oncology, dermatology, and ophthalmology. Owing to higher prevalence of chronic diseases, genetic diseases, and aging population, causing a higher requirement for organs and biomaterials for tissue regeneration, the regenerative medicine market has escalated to be valued in between $26 billion-$27 billion as of 2018. The analyst of this business intelligence report has tracked this developing marketplace to be progressing economically at a CAGR of 22%-24% during the forecast period 2019-2025.

Regenerative Medicine Market Outlook:

According to Global Burden of Disease, a study by WHO, musculoskeletal conditions are the second highest contributor to global disability. And, Institute for Health Metrics and Evaluation (IHME) has revealed that the total burden of disability increased by 52% between 1990 and 2017.

Gene therapy and tissue engineering in orthopedic surgery endures to assist as the foundation for innovative treatments of innumerable musculoskeletal disorders. Regenerative medicine market is all established to capitalize on the global musculoskeletal disorder rate as it assists in tissue engineering and therapy. Due to such occurrences, orthopedic & musculoskeletal cases dominate the application segment and is flourishing with an application CAGR of 21%-23% going through 2025.

After an acute analysis of the regional aspects of regenerative medicine market, North America has been located as the leading region encapsulating under its terrain around 30%-32% of the global regenerative medicine market demand. The sheer affluence of this region can be attributed to several facts. The United States with its existing modern and cutting-edge healthcare infrastructure is compatible for intricate medical outputs such as stem cell and oncology research augmenting regenerative market. Accelerating frequency of ailments, for instance cancer and diabetes, in the United Sates is positively affecting the market. National Cancer Institute estimated the nationwide expenses for cancer care in the United States in 2017 were $147.3 billion[2]. Similarly 23.1 million folks in the United States are diagnosed with diabetes at a cost of more than $245 billion per year[3]. Awareness among population regarding the available stem cell procedures and therapies effectively curing cancer and diabetes is increasing, which consequence in increasing the demand for the regenerative medicine market.

Regenerative Medicine Market Growth Drivers and Trends:

One of the major drivers of regenerative medicine market is the growing research and developments activities and innovations and funding in biomaterials, nanotechnology, drug delivery, and cell therapies.

The 21st Century Cures Act, approved in December 2016, created room for establishment of Regenerative Medicine Innovation Project (RMIP). NIH (National Institute of Health) is leading the RMIP in coordination with FDA. The 21st Century Cures Act approved $30 million in federal awards over four years (2017-2020) for the RMIP, thus accelerating the arena by aiding clinical research on mature stem cells while endorsing the uppermost morals for scientific research and patient safety[4].

Socio-economic context is restricting folks from developing economies to afford organ transplantation. Inadequate stock of organs is instigating serious crime of organ trafficking common in Pakistan, India, and China. This circumstantial setting requires to be disrupted with abrupt response and demands for discovery an alternative source of organ transplantation such as regenerative medicine.

Regenerative Medicine Market Challenges:

Emerging economies with mounting instances of chronic diseases, genetic diseases, and aging population, where there is a higher demand for organs and biomaterials for tissue regeneration have low awareness of developments in regenerative medicine due to low healthcare expenditure.

But however, research and developments with adequate influx of investments and funding are progressing towards economical commercialization of such intricate medical procedures.

Regenerative Medicine Market Players Perspective:

Vertex Pharmaceuticals Incorporated, Medtronic Plc, Allegan Plc, Smith & Nephew Plc, Nuvasive, Inc, Cytori Therapeutics, Inc, Vericel Corporation, BlueRock Therapeutics, Octane Biotech Inc, and Theracell Advanced Biotechnology Ltd are some of the key players functional and effective in the regenerative medicine market.

Vertex Pharmaceuticals Incorporated, revealed on February 12, 2018 that their third medicine SYMDEKO™ got approved by FDA for cystic fibrosis (CF), a genetic disorder that affects mostly the lungs, but also the pancreas, liver, kidneys, and intestine. Such developments curate the future revenue for regenerative medicine market.

Regenerative Medicine Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the regenerative medicine market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the various researches in regenerative medicine market, and their specific applications in different types of ailments.

Regenerative Medicine Market Report: Industry Coverage

By Products: Analyzers, Reagents

End Users: Hospitals, Clinical Laboratories, Academics

By Applications: Oncology, Microbiology, Others

The regenerative medicine market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

Middle East and Africa: Israel, South Africa, Saudi Arabia

Key Questions Addressed in the Regenerative Medicine Market Report

1. Is the market for regenerative medicine growing? How long will it continue to grow and at what rate?

2. Which type of diagnostics presents the major growth opportunities?

3. Is there a possibility for change in the market structure over time?

4. Are additional developments needed for the existing product or services offerings or do the existing products meet the customer demands?

5. Do the key vendors look for partnerships to expand their businesses with respect to geography or product?

6. What are the short-term, long-term, and medium-term growth drivers for the market?

7. What are the short-term, medium-term, and long-term challenges for the market?

8. What are the short-term, medium-term, and long-term opportunities for the market

9. Who are the top players/companies of the market?

10. What are the recent innovations in the market?

11. How many patents have been filed by the leading players?

12. What are the types of patents filed by the leading players?

13. What is our Vision 2030 for Regenerative Medicine Market?

A few focus points of this Research are given below:

Give a deep-dive analysis of the key operational strategies with focus on the corporate structure, R&D strategies, localization strategies, production capabilities, and sales performance of various companies

Provide an overview of the product portfolio, including product planning, development, and positioning

Discuss the role of technology companies in partnerships

Explore the regional sales activities

Analyze the market size and giving the forecast for current and future regenerative medicine during the forecast 2018-2023

Analyze the competitive factors, competitors' market shares, product capabilities, and supply chain structures

1. Regenerative Medicine Market - Market Overview

  • 1.1. Definitions and Scope

2. Regenerative Medicine Market - Executive Summary

  • 2.1. Market Revenue, Market Size and Key Trends by Company
  • 2.2. Key Trends Segmented by Geography

3. Regenerative Medicine Market - Market Landscape

  • 3.1. Comparative Analysis
    • 3.1.1. Product Benchmarking - Top 10 Companies
    • 3.1.2. Top 5 Financials Analysis
    • 3.1.3. Market Value Split by Key Companies
    • 3.1.4. Pricing Analysis

4. Regenerative Medicine Market - Startup Companies Scenario

  • 4.1. Key Startup Company Analysis by
    • 4.1.1. Investment
    • 4.1.2. Revenue
    • 4.1.3. Venture Capital and Funding Scenario

5. Regenerative Medicine Market - Market Forces

  • 5.1. Drivers
  • 5.2. Constraints & Challenges
  • 5.3. Porter's Five Force Model
    • 5.3.1. Bargaining Power of Suppliers
    • 5.3.2. Bargaining Power of Customers
    • 5.3.3. Threat of New Entrants
    • 5.3.4. Rivalry Among Existing Players
    • 5.3.5. Threat of Substitutes

6. Regenerative Medicine Market - Strategic Analysis

  • 6.1. Value Chain Analysis
  • 6.2. Opportunities Analysis
  • 6.3. Market Life Cycle

7. Regenerative Medicine Market - By Therapy (Market Size - $Million/$Billion)

  • 7.1. Market Size and Market Share Analysis
  • 7.2. Therapy Segment Analysis
    • 7.2.1. Cell Therapy
    • 7.2.2. Gene Therapy
    • 7.2.3. Tissue Engineering
    • 7.2.4. Others

8. Regenerative Medicine Market - By Product (Market Size - $Million/$Billion)

  • 8.1. Market Size and Market Share Analysis
  • 8.2. Product Segment Analysis
    • 8.2.1. Cell-Based Products
      • 8.2.1.1. Allogeneic Products
      • 8.2.1.2. Autologous Products
    • 8.2.2. Acellular Products

9. Regenerative Medicine Market - By Material (Market Size - $Million/$Billion)

  • 9.1. Market Size and Market Share Analysis
  • 9.2. Material Segment Analysis
    • 9.2.1. Synthetic Material
      • 9.2.1.1. Biodegradable Synthetic Polymers
      • 9.2.1.2. Scaffold
      • 9.2.1.3. Artificial Vascular Graft Materials
      • 9.2.1.4. Hydrogel Materials
    • 9.2.2. Biologically Derived Material
      • 9.2.2.1. Collagen
      • 9.2.2.2. Xenogeneic Material
    • 9.2.3. Genetically Engineered Material
      • 9.2.3.1. Genetically Manipulated Cells
      • 9.2.3.2. 3D Polymer Technology
      • 9.2.3.3. Transgenic
      • 9.2.3.4. Fibroblast
      • 9.2.3.5. Neural Stem Cells
      • 9.2.3.6. Gene-activated Matrices
    • 9.2.4. Pharmaceutical
      • 9.2.4.1. Small Molecules
      • 9.2.4.2. Biologics

10. Regenerative Medicine Market - By Application (Market Size - $Million/$Billion)

  • 10.1. Market Size and Market Share Analysis
  • 10.2. Application Segment Analysis
    • 10.2.1. Orthopedic & Musculoskeletal
    • 10.2.2. Cardiovascular
    • 10.2.3. Oncology
    • 10.2.4. Dermatology
    • 10.2.5. Neurology
    • 10.2.6. Ophthalmology
    • 10.2.7. Hematology & Immunology
    • 10.2.8. Diabetes
    • 10.2.9. Esophagus
    • 10.2.10. Dental
    • 10.2.11. Others

11. Regenerative Medicine Market - By Geography (Market Size - $Million/$Billion)

  • 11.1. Regenerative Medicine Market - North America Segment Research
  • 11.2. North America Market Research (Market Size - $Million/$Billion)
    • 11.2.1. Segment Size and Market Size Analysis
    • 11.2.2. Revenue and Trends
    • 11.2.3. Therapy Analysis
    • 11.2.4. Product Industry Analysis
    • 11.2.5. Material Industry Analysis
    • 11.2.6. Application Analysis
    • 11.2.7. North America Segment Analysis
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Regenerative Medicine Market - South America Segment Research
  • 11.4. South America Market Research (Market Size - $Million/$Billion)
    • 11.4.1. Segment Size and Market Size Analysis
    • 11.4.2. Revenue and Trends
    • 11.4.3. Therapy Analysis
    • 11.4.4. Product Industry Analysis
    • 11.4.5. Material Industry Analysis
    • 11.4.6. Application Analysis
    • 11.4.7. South America Segment Analysis
      • 11.4.7.1. Brazil
      • 11.4.7.2. Chile
      • 11.4.7.3. Argentina
      • 11.4.7.4. Rest of South America
  • 11.5. Regenerative Medicine Market - Europe Segment Research
  • 11.6. Europe Market Research (Market Size - $Million/$Billion)
    • 11.6.1. Segment Size and Market Size Analysis
    • 11.6.2. Revenue and Trends
    • 11.6.3. Therapy Analysis
    • 11.6.4. Product Industry Analysis
    • 11.6.5. Material Industry Analysis
    • 11.6.6. Application Analysis
    • 11.6.7. Europe Segment Analysis
      • 11.6.7.1. U.K.
      • 11.6.7.2. Germany
      • 11.6.7.3. Italy
      • 11.6.7.4. France
      • 11.6.7.5. Russia
      • 11.6.7.6. Spain
      • 11.6.7.7. Rest of Europe
  • 11.7. Regenerative Medicine Market - APAC Segment Research
  • 11.8. Asia Pacific Market Research (Market Size - $Million/$Billion)
    • 11.8.1. Segment Size and Market Size Analysis
    • 11.8.2. Revenue and Trends
    • 11.8.3. Therapy Analysis
    • 11.8.4. Product Industry Analysis
    • 11.8.5. Material Industry Analysis
    • 11.8.6. Application Analysis
    • 11.8.7. APAC Segment Analysis
      • 11.8.7.1. China
      • 11.8.7.2. Australia
      • 11.8.7.3. Japan
      • 11.8.7.4. South Korea
      • 11.8.7.5. India
      • 11.8.7.6. Rest of APAC
  • 11.9. Regenerative Medicine Market - Middle East Segment and Africa Segment Research
  • 11.10. Middle East and Africa Market Research (Market Size - $Million/$Billion)
    • 11.10.1. Segment type Size and Market Size Analysis
    • 11.10.2. Revenue and Trends
    • 11.10.3. Therapy Analysis
    • 11.10.4. Product Industry Analysis
    • 11.10.5. Material Industry Analysis
    • 11.10.6. Application Analysis
    • 11.10.7. Middle East & Africa Segment Analysis
      • 11.10.7.1. Middle East
      • 11.10.7.2. Africa

12. Regenerative Medicine Market - Market Entropy

13. Regenerative Medicine Market Company Analysis

  • 13.1. Market Share, Company Revenue, Products, M&A, Developments
  • 13.2. Vertex Pharmaceuticals Inc. (U.S.)
  • 13.3. Medtronic Plc (Ireland)
  • 13.4. NuVasive, Inc. (U.S.)
  • 13.5. Integra LifeSciences Holdings Corporation (U.S.)
  • 13.6. Smith & Nephew Plc (U.K.)
  • 13.7. Mesoblast Ltd. (Australia)
  • 13.8. Vericel Corporation (U.S.)
  • 13.9. Athersys, Inc. (U.S.)
  • 13.10. Exactech, Inc. (U.S.)
  • 13.11. Company 10
  • 13.12. Company 11
  • 13.13. Company 12 and more

"*Financials of private companies will be provided on a best-efforts basis"

14. Regenerative Medicine Market - Appendix

  • 14.1. Abbreviations
  • 14.2. Sources

15. Regenerative Medicine Market - Methodology

  • 15.1. Research Methodology
    • 15.1.1. Company Expert Interviews
    • 15.1.2. Industry Databases
    • 15.1.3. Associations
    • 15.1.4. Company News
    • 15.1.5. Company Annual Reports
    • 15.1.6. Application Trends
    • 15.1.7. New Products and Product Database
    • 15.1.8. Company Transcripts
    • 15.1.9. R&D Trends
    • 15.1.10. Key Opinion Leaders Interviews
    • 15.1.11. Supply and Demand Trends